Prognostic factors of renal cell carcinoma: A multivariate analysis

Journal of Surgical Oncology

Volumn 68, Issue 1, 1998, Pages 11-18

  Yasunaga, Yutaka ^a   Shin, Masaru ^a   Miki, Tsuneharu ^a   Okuyama, Akihiko ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Multivariate analysis; Prognostic factors; Renal cell carcinoma; Silver stained nucleolar organizer regions (AgNORs)

Indexed keywords

ALPHA INTERFERON; CISPLATIN; DOXORUBICIN; GAMMA INTERFERON; METHOTREXATE; UFT; VINCRISTINE;

ABDOMINAL MASS; ADULT; AGED; ANEMIA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CHROMOSOME NOR; FEMALE; HEMATURIA; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PAIN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEOLUS ORGANIZER REGION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SILVER STAINING;

EID: 0031748713     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199805)68:1<11::AID-JSO4>3.0.CO;2-O     Document Type: Article

References (43)

1. Van der Poel HG, Mulders PFA, Oosterhof GON, et al.: Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Cancer 1993;72:2667-2674.
2. Ulchaker JC, Klein EA: Biology of metastasis and its clinical implications: Renal-cell cancer. World J Urol 1996;14:175-181.
3. Bretheau D, Lechevallier E, de Fromont M, et al.: Prognostic value of nuclear grade of renal cell carcinoma. Cancer 1995;76: 2543-2549.
4. Bot FJ, Godschalk JCJ, Krishnadath KK, et al.: Prognostic factors in renal-cell carcinoma: Immunohistochemical detection of p53 protein versus clinico-pathological parameters. Int J Cancer 1994; 57:634-637.
5. Shimazui T, Tomobe M, Hattori K, et al.: A prognostic significance of nucleolar organizer region (AgNOR) in renal cell carcinoma. J Urol 1995;154:1522-1526.
6. Uhlman DL, Nguyen PL, Manivel C, et al.: Association of imunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma. J Natl Cancer Inst 1994;86:1470-1475.
7. Delahunt B, Bethwaite PB, Nacey JN, Ribas JL: Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: Comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers. J Pathol 1993;170:471-477.
8. Thrasher JB, Paulson DF: Prognostic factors in renal cancer. Urol Clin North Am 1993;20:247-262.
9. Delahunt B, Bethwaite PB, Thornton A, Ribas JL: Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Cancer 1995;75:2714-2719.
10. Flint A, Grossman HB, Liebert M, et al.: DNA and PCNA content of renal cell carcinoma and prognosis. Am J Clin Pathol 1995; 103:14-19.
11. Cronin KJ, Williams NN, Kerin MJ, et al.: Proliferating cell nuclear antigen: A new prognostic indicator in renal cell carcinoma. J Urol 1994;152:834-836.
12. Tannapfel A, Hahn HA, Katalinic A, et al.: Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Cancer 1996;77:164-171.
13. de Riese WTW, Crabtree WN. Allhoff EP, et al.: Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma. J Clin Oncol 1993;11:1804-1808.
14. Hofmockel G, Tsatalpas P, Müller H. et al.: Significance of conventional and new prognostic factors for locally confined renal cell carcinoma. Cancer 1995;76:296-306.
15. Jochum W, Schröder S, Al-Taha R, et al.: Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. Cancer 1996;77:514-521.
16. Underwood JCE, Giri DD: Nucleolar organizer regions as diagnostic discriminants for malignancy. J Pathol 1988;155:95-96.
17. Ploton D, Menager M, Jeannesson P, et al.: Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer regions at the optical level. Histochem J 1986; 18:5-14.
18. Delahunt B, Ribas JL, Nacey JN, Bethwaite PB: Nucleolar organizer regions and prognosis in renal cell carcinoma. J Pathol 1991; 163:31-37.
19. Yang AH, Wang TY, Liu HC: Comparative study of the prognostic value of nuclear grade and silver-binding nucleolar organizer region in renal cell carcinomas. J Pathol 1992;166:157-161.
20. Pich A, Chiusa L, Margaria E: Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis. Cancer Detect Prevent 1995;19:282-291.
21. Kuratsu S, Aozasa K, Myoui A, et al.: Prognostic significance of argyrophilic nucleolar organizer staining in soft-tissue sarcomas. Int J Cancer 1991;48:211-214.
22. Kuratsu S, Tomita Y, Myoui A, et al.: DNA ploidy pattern and cell cycle stage of tumor cells in soft-tissue sarcomas: clinical implications. Oncology 1995;52:363-370.
23. Hermanek P, Sobin L: "Classification of Malignant Tumours," 4th ed. Berlin: Springer-Verlag, 1988.
24. Mostofi FK: "Histological Typing of the Kidney Tumors." Genova: WHO, 1981.
25. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-663.
26. Mourad WA, Nestok BR, Saleh GY, et al.: Dysplastic tubular epithelium in "normal" kidney associated with renal cell carcinoma. Am J Surg Pathol 1994;18:1117-1124.
27. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
28. Peto R, Pike MC, Armitage P, et al.: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 1977;35:1-39.
29. Cox DR: Regression models and life-tables. J R Stat Soc (B) 1972;34:187-220.
30. JMP; Statistical visualization software, 1994, SAS, Tokyo.
31. Lieber MM, Tomera FM, Taylor WF, Farrow GM: Renal adenocarcinoma in young adults: survival and variables affecting prognosis. J Urol 1981;125:164-168.
32. Ljungberg B, Joanssen H, Stenling R: Prognostic factors in renal cell carcinoma. Int Urol Nephrol 1988;20:115-121.
33. Papadopoulos I, Rudolph P, Weichen JK, et al.: Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon alpha-2 beta and vinblastine. Urology 1996;48:373-378.
34. Selli C, Hinshaw WM, Woodard BH, Paulson DF: Stratification of risk factors in renal cell carcinoma. Cancer 1983;52:899-903.
35. McNichols DW, Segura JW, DeWeerd JH: Renal cell carcinoma: Long-term survival and late recurrence. J Urol 1981;126:17-23.
36. Targonski PV, Frank W, Stuhldreher D, Guinan PD: Value of tumor size in predicting survival from renal cell carcinoma among tumors, nodes and metastases stage 1 and stage 2 patients. J Urol 1994;152:1389-1392.
37. Delahunt B, Nacey JN: Renal cell carcinoma II. Histological indicators of prognosis. Pathology 1987;19:258-263.
38. Munichor M, Lichtig C, Tzin G, Weiss A: Prognostic significance of granular cell content in renal cell carcinoma. Eur Urol 1992; 22:204-208.
39. Mancilla-Jimenez R, Stanley RJ, Blath RA: Papillary renal cell carcinoma: A clinical radiologic and pathologic study of 34 cases. Cancer 1978;38:2469-2480.
40. Shouman M, Warter A, Roos M, Bollock C: Renal cell carcinoma: Statistical study of survival based on pathological criteria. World J Urol 1984;2:109-113.
41. Medeiros LJ, Gelb AB, Weiss LM: Renal cell carcinoma: Prognostic significance of morphologic parameters in 121 cases. Cancer 1988;61:1639-1651.
42. Oda H, Machinami R: Sarcomatoid renal cell carcinoma: A study of its proliferative activity. Cancer 1993;71:2292-2298.
43. Oda H, Nakatsuru Y, Ishikawa T: Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res 1995;55:658-662.